News

Smart for Life Launches Proprietary New Line of High Protein Ice Cream

Smart for Life Launches Proprietary New Line of Protein-Based Ice Cream Smart for Life Launches Proprietary New Line of Protein-Based…

2 years ago

Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326

BEFORE Unretouched photos, taken in standard lighting. Results may vary. AFTER Unretouched photos, taken in standard lighting. Results may vary.…

2 years ago

GRI Bio (NASDAQ: GRI) Announces Appointment of Leanne Kelly as Chief Financial Officer

- Financial executive bringing over 20 years of experience in accounting, finance and management with a foundation established from big…

2 years ago

Bon Natural Life Limited Appoints Wallace Lee as New Chief Financial Officer

XIAN, China, April 25, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of…

2 years ago

Aphaia Pharma Announces Dosing of First Patient in its Phase 2 Trial Evaluating its Lead Candidate APH-012 for Prediabetes

ZUG, Switzerland and SAN JUAN, Puerto Rico, April 25, 2023 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage company harnessing precision-targeted…

2 years ago

Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on…

2 years ago

Artelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss

SOLANA BEACH, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways…

2 years ago

Health Catalyst to Announce First Quarter 2023 Operating Results and Host Conference Call on Tuesday, May 9, 2023

SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of…

2 years ago

Allogene Therapeutics to Report First Quarter 2023 Financial Results on May 3, 2023

Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., April 25, 2023 (GLOBE NEWSWIRE) --…

2 years ago